HEALTHSTORY 641· JUNE 25, 2026

BIO 2026 in San Diego: China's Drug-Development Push and the AI Imperative Dominate the Industry Agenda

The annual international BIO conference in San Diego brought biotech and startup executives face-to-face with two forces reshaping the global drug industry: China's deepening capabilities in drug development and the early competitive…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 640Supreme Court Rules Asylum Seekers Must Physically Cross the Border Before U.S. Law Applies NEXT STORY 642 →Bitcoin at $58,000: Power-Law Model Calls the Drop a Normal Cycle Low as Futures Point Lower

Keep reading

More from the desk.

07HEALTH

States must begin notifying Medicaid enrollees about new work requirements and eligibility rules in September

People covered by Medicaid, the joint federal-state health insurance program for low-income individuals, face new enrollment rules that take effect in 2027. The One Big Beautiful Bill Act of 2025 introduced those changes on what the law…

health2 MIN

09HEALTH

NIH moves to cut visa-holding researchers from a key early-career grant

A major federal science agency is moving to restrict one of its most sought-after early-career grants, called a K99/R00 award, which is a two-part fellowship that funds postdoctoral training and then a researcher's first years running an…

health2 MIN

10HEALTH

Sanofi Pompe disease drug shortage hits Myozyme and Nexviazyme as FDA flags Waterford plant

Two medicines used to treat Pompe disease, a rare inherited muscle disorder caused by the abnormal buildup of glycogen in the body's cells, are running short across the United States and Europe. Sanofi, which manufactures both drugs, has…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk